This content is machine translated Pompe's disease Further development of enzyme replacement therapy provides new treatment option New data from the open-label, long-term extension of the randomized, double-blind, Phase 3 COMET study show that people with late-stage Pompe disease (LOPD) maintained improvements in respiratory function and mobility…